Condition: Opioid-Refractory Chronic Cancer-Related Pain · Sponsor: National and Kapodistrian University of Athens
This is a randomized, double-blinded, placebo-controlled, cross-over trial examining the effect of a series of two weekly intravenous infusions of lidocaine 4 mg/kg and ketamine 0.2 mg/kg in patients with moderate to severe opioid-refractory chronic cancer-related pain. The aim of this study is to investigate whether the lidocaine - ketamine (LK) regimen provides better analgesia that an active placebo of midazolam 0.02 mg/kg, in this population.
This description comes directly from the study's public registry record.
Konstantinos Kalimeris MD, PhD, Associate Professor of Anesthesiology, Associate Professor · +302105831997 · kkalimeris@med.uoa.gr
Erond Zeneli MD, PhD candidate · +306982094129 · erond.zeneli@gmail.com
Always discuss trial participation with your own doctor first.
| University General Hospital of Athens "Attikon" - National and Kapodistrian University of Athens Medical School | Athens, Attica, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07408193